Celebrating another great year at SickKids!

SickKids implants the first Responsive Neurostimulation Device in Canada to treat drug-resistant epilepsy

The interdisciplinary team from SickKids’ Comprehensive Epilepsy Program led the first implantation of an RNS device in a patient living with drug-resistant epilepsy.

Whole genome sequencing reveals new genetic marker for cardiomyopathy

Using computational methods developed at SickKids, scientists identify tandem repeats are expanded in DNA of patients with cardiomyopathy.

Genetic causes of cerebral palsy uncovered through whole-genome sequencing

Canadian scientists demonstrate that cerebral palsy may be caused by both genetic and environmental factors, informing diagnosis and care for the diverse condition.

SickKids surgeons use “smart glasses” to telementor in low-resource countries

Mentors can share specialized surgical skills in real time to mentees across the globe using a virtual interactive presence.

Gene therapy halts progression of rare genetic condition in young boy

The findings from SickKids’ first single-patient gene therapy trial show promise in halting the progression of SPG50.

Inherited gene variations reveal precision therapy potential for rare cancer syndrome

Global research led by SickKids finds new strategies to help diagnose and treat a rare and aggressive cancer predisposition syndrome.

Re-imagining the patient and family experience: SickKids launches new Patient and Family Experience Strategy

Designed with input from patients, families, staff and the community, this strategy will be a blueprint for a more human-centred experience across care, research and education at SickKids.

Electronic tool helps integrate mental health care in each clinical encounter

A new measurement-based care initiative, led by the Mental Health Strategy, is helping integrate mental health care into the care continuum.

SickKids #2 in World’s Best Specialized Hospitals ranking by Newsweek

SickKids is proud to be named one of the World’s Best Specialized Hospitals (Pediatrics) for 2025 by Newsweek and Statista.

Code Orange: How SickKids plans for the unimaginable

In a Code Orange – disaster activation, SickKids staff must mobilize and collaborate seamlessly on very short notice. Staff engage in a hospital-wide simulation as an essential way to plan and manage their response to multiple or mass casualty events.

Clinical trial explores new approach to childhood brain cancer treatment

The first clinical trial to investigate treatment for childhood glioblastoma without radiation and chemotherapy has opened at SickKids.

Precision robotics offers hope for heart disease treatment

The advanced drug testing system screens multiple potential therapies simultaneously in beating heart cells.

Genetic discovery links new gene to autism spectrum disorder

Variants in the DDX53 and other genes on the X chromosome provide genetic clues to male prevalence in ASD.

SickKids ranked one of Canada’s Top 40 Research Hospitals for 2024

SickKids holds a top spot for both researcher intensity and hospital intensity as one of Canada's Top 40 Research Hospitals.

SickKids scientists among the most influential in the world in 2024

The researchers are among 206 Canadian scientists on Clarivate’s Highly Cited Researchers 2024 list.